No connection

Search Results

NUWE vs TIVC

NUWE
Nuwellis, Inc.
BEARISH
Price
$1.23
Market Cap
$3.2M
Sector
Healthcare
AI Confidence
95%
TIVC
Tivic Health Systems, Inc.
BEARISH
Price
$1.13
Market Cap
$3.3M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
NUWE
--
TIVC
--
Forward P/E
NUWE
-0.47
TIVC
-0.05
P/B Ratio
NUWE
0.79
TIVC
0.17
P/S Ratio
NUWE
0.39
TIVC
--
EV/EBITDA
NUWE
-0.19
TIVC
0.37

Profitability

Gross Margin
NUWE
61.96%
TIVC
0.0%
Operating Margin
NUWE
-100.78%
TIVC
0.0%
Profit Margin
NUWE
-211.86%
TIVC
0.0%
ROE
NUWE
-382.55%
TIVC
-82.69%
ROA
NUWE
-86.86%
TIVC
-28.69%

Growth

Revenue Growth
NUWE
4.4%
TIVC
--
Earnings Growth
NUWE
--
TIVC
--

Financial Health

Debt/Equity
NUWE
0.12
TIVC
0.38
Current Ratio
NUWE
1.71
TIVC
20.13
Quick Ratio
NUWE
0.85
TIVC
19.57

Dividends

Dividend Yield
NUWE
--
TIVC
--
Payout Ratio
NUWE
0.0%
TIVC
0.0%

AI Verdict

NUWE BEARISH

Nuwellis, Inc. exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a devastating 1-year price decline of 96.9%. While the company maintains a low debt-to-equity ratio, its profitability metrics are catastrophic, with a profit margin of -211.86% and an ROE of -382.55%. Revenue growth is stagnant at 4.4%, failing to offset massive operational losses. The technical trend is completely bearish (0/100), suggesting a lack of investor confidence and a high risk of further capital erosion.

Strengths
Low Debt/Equity ratio (0.12)
Strong Gross Margin (61.96%)
Current Ratio above 1.0 (1.71)
Risks
Extreme operational losses (Profit Margin -211.86%)
Severe financial instability (Piotroski F-Score 1/9)
Massive loss of shareholder value (-96.9% 1Y change)
TIVC BEARISH

TIVC exhibits severe financial distress, anchored by a Piotroski F-Score of 1/9, indicating critical weakness across nearly all fundamental health dimensions. Despite a high current ratio suggesting short-term liquidity, the company is experiencing a catastrophic collapse in revenue (-267.78% Q/Q) and a near-total loss of shareholder value over a 5-year horizon (-100%). While the stock trades at a deep discount to book value (P/B 0.17), the lack of profitability and negative ROE (-82.69%) suggest a value trap rather than a value opportunity.

Strengths
Extremely high current ratio (20.13) indicating strong short-term liquidity
Low Debt/Equity ratio (0.38) relative to healthcare sector average
Recent quarterly earnings beats (though still deeply negative)
Risks
Catastrophic Q/Q revenue decline of -267.78%
Severe long-term price erosion (99.5% loss over 3 years)
Critical Piotroski F-Score of 1/9 signaling fundamental failure

Compare Another Pair

NUWE vs TIVC: Head-to-Head Comparison

This page compares Nuwellis, Inc. (NUWE) and Tivic Health Systems, Inc. (TIVC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile